Bangladesh, like most other developing countries, is now facing the daunting task of procuring Covid-19 vaccines, as the world witnesses unprecedented inequities in vaccine access. It is true that Bangladesh is one of the few nations that succeeded in securing 30 million doses of the Oxford- AstraZeneca vaccines, allowing us to get an early start of nationwide inoculation programme. But, the Indian producer of the Oxford- AstraZeneca vaccine, the Serum Institute (SI), now says they will not be able to export Covid-19 vaccines before June-July. As a result, Nazmul Hassan Papon, managing director of Beximco, the Bangladeshi supplier of the vaccines from SI, says as Bangladesh has paid in advance for the vaccines, the SI has no right to halt the supply. He now turned to the government and seeks diplomatic intervention. But, it is unlikely that India, amidst its worst public health crisis due to record surge in Covid19 transmission and deaths, would be easing the ban on vaccine exports any...